Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
Markets
Equities
North America
Europe
Asia
Oceania
Middle East
»
More Equities
Indexes
S&P 500
DOW JONES
NASDAQ 100
EURO STOXX 50
NIKKEI 225
»
More Indexes
Currency / Forex
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
»
More Currencies
Commodities
GOLD
Crude Oil (WTI)
Crude Oil (BRENT)
SILVER
PLATINUM
»
More Commodities
Trackers & ETF
Rankings and News
Advanced Search
Cryptocurrencies
BITCOIN
ETHEREUM
News
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Business Leaders
Cryptocurrencies
Cybersecurity
Economic Calendar
Listed companies
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Events
Security Transactions
Financial Calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Telecommunications Services
Utilities
Analysis
All Analysis
Must Read
Daily Briefing
Weekly market update
Stock Trading Strategies
Stock Picks
All Stock Picks
Subscribe
Portfolios
My Portfolio
Virtual Portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
Watchlists
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
Growth stocks
Momentum stocks
Yield stocks
Trend-Following Stocks
Multibaggers
Quality stocks
Investment Themes
Education
Millennials
Blockchain
Let’s all cycle!
Oligopolies
Wind energy
Rankings
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top ranking ESG
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
Screeners
Investment Themes
Education
Millennials
Blockchain
Let’s all cycle!
Oligopolies
Wind energy
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
Tools
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Dynamic Chart
Financial Calendar
Economic Calendar
Apprendre la bourse
ProRealTime Trading
Our Services
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
Homepage
Equities
United States
Nasdaq
HCW Biologics Inc.
News
Summary
HCWB
US40423R1059
HCW BIOLOGICS INC.
(HCWB)
Add to my list
Report
Delayed Nasdaq -
05/16 04:00:00 pm EDT
2.110
USD
+7.11%
05/13
Earnings Flash (HCWB) HCW BIOLOGICS Reports Q1 Revenue $3.12M
MT
05/13
HCW BIOLOGICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
05/13
HCW Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
HCW Biologics Inc.(NasdaqGM:HCWB) added to S&P TMI Index
09/20/2021 | 12:00am EDT
Send by mail :
Name :
First name :
From
*
:
To
*
:
(You can enter multiple email addresses separated by commas)
Message :
*
Required fields
HCW Biologics Inc.(NasdaqGM:HCWB) added to S&P TMI Index
© S&P Capital IQ 2021
All news about HCW BIOLOGICS INC.
05/13
Earnings Flash (HCWB) HCW BIOLOGICS Reports Q1 Revenue $3.12M
MT
05/13
HCW BIOLOGICS INC. Management's Discussion and Analysis of Financial Condition and Res..
AQ
05/13
HCW Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/13
HCW Biologics Reports First Quarter 2022 Financial Results and Recent Business Highligh..
GL
05/13
HCW Biologics Reports First Quarter 2022 Financial Results and Recent Business Highligh..
AQ
05/05
HCW Biologics to Showcase Two Novel Groups of Fusion Molecules Created with Proprietary..
GL
05/05
HCW Biologics to Showcase Two Novel Groups of Fusion Molecules Created with Proprietary..
AQ
04/19
HCW Biologics' CEO Hing C. Wong, Ph.D., to be Featured Speaker at the Third Annual Inte..
AQ
03/29
HCW BIOLOGICS INC. Management's Discussion and Analysis of Financial Condition and Res..
AQ
03/29
HCW Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
More news
Analyst Recommendations on HCW BIOLOGICS INC.
03/24
Maxim Initiates HCW Biologics at Buy With $4 Price Target
MT
More recommendations
Financials (USD)
Sales 2022
-
-
-
Net income 2022
-18,3 M
-
-
Net Debt 2022
-
-
-
P/E ratio 2022
-3,30x
Yield 2022
-
Capitalization
75,5 M
75,5 M
-
Capi. / Sales 2022
-
Capi. / Sales 2023
-
Nbr of Employees
44
Free-Float
25,0%
More Financials
Chart HCW BIOLOGICS INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Full-screen chart
Technical analysis trends HCW BIOLOGICS INC.
Short Term
Mid-Term
Long Term
Trends
Bearish
Neutral
Bearish
Technical analysis
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
More Financials
Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2,11 $
Average target price
7,00 $
Spread / Average Target
232%
Consensus
EPS Revisions
Please enable JavaScript in your browser's settings to use dynamic charts.
More Estimates Revisions
Managers and Directors
Hing C. Wong
Chief Executive Officer, Secretary & Director
Rebecca Byam
Chief Financial Officer
Scott T. Garrett
Chairman
Peter R. Rhode
Chief Scientific Officer & VP-Clinical Operations
Rick Scott Greene
Independent Director
More about the company
Sector and Competitors
1st jan.
Capi. (M$)
HCW BIOLOGICS INC.
-9.05%
71
GILEAD SCIENCES, INC.
-14.10%
78 232
REGENERON PHARMACEUTICALS, INC.
2.22%
69 552
VERTEX PHARMACEUTICALS
12.35%
63 100
WUXI APPTEC CO., LTD.
-16.67%
43 023
BIONTECH SE
-38.39%
38 601
More Results
Slave